Skip to main content

Advertisement

SpringerLink
Log in

The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

The influence of chronic lymphocytic thyroiditis (CLT) on clinicopathological features and behavior of differentiated thyroid carcinoma (DTC) is still debated. In the present study, we aimed to evaluate the prognosis of DTC on the presence of CLT. A total of 649 total thyroidectomized patients (379 female, 270 male) with DTC, who had follow-up data for at least 36 months were included. Clinical, histopathological data, preoperative thyroid peroxidase antibody (TPO-ab), thyroglobulin antibody (Tg-ab), thyroid-stimulating hormone (TSH) levels, and presence of recurrent/persistent disease (R/PD) were evaluated retrospectively. Presence of CLT was defined by histopathology. Frequency of CLT was 32% (n = 208) among DTC patients. Mean tumor size (maximal diameter) was smaller in CLT group when compared to non-CLTs (p = 0.006). Capsular invasion, vascular invasion, tumor stage, risk groups, and R/PD were negatively associated with CLT (p < 0.01, p = 0.04, p = 0.03, p = 0.02, p < 0.01, respectively). Extrathyroidal extension was more frequent in non-CLT group when compared CLT (p = 0.052). Preoperative TSH level was positively associated with lymph node metastasis (LNM) and higher in patients with lateral LNM when compared to central LNM (p < 0.01). Central LNM, lateral LNM, stage 4 tumor, and intermediate- and high-risk tumor groups increased the risk of R/PH, 2.5-, 2.9-, 12.7-, 2.3-, and 4.2-fold, respectively. Presence of CLT was independently related with favorable outcomes, as the risk of R/PD was decreased by 0.49-fold. In conclusion, coexistence of CLT was negatively associated with tumor size, capsular invasion, vascular invasion, and tumor stage in DTC. Risk of R/PD was decreased by approximately half in patients with CLT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA archives of surgery. 1955;70(2):291-7. PubMed PMID: 13227748.

    Article  CAS  Google Scholar 

  2. Lee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. European journal of endocrinology / European Federation of Endocrine Societies. 2013;168(3):343-9. PubMed PMID: 23211578.

    Article  CAS  Google Scholar 

  3. Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World journal of surgery. 2001;25(5):632-7. PubMed PMID: 11369991.

    Article  CAS  Google Scholar 

  4. Jeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. Journal of Korean medical science. 2012;27(8):883-9. PubMed PMID: 22876054. Pubmed Central PMCID: 3410235.

  5. Kim KW, Park YJ, Kim EH, Park SY, Park DJ, Ahn SH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head & neck. 2011;33(5):691-5. PubMed PMID: 21484918.

    Article  Google Scholar 

  6. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. The Laryngoscope. 1997;107(1):95-100. PubMed PMID: 9001272.

    Article  CAS  Google Scholar 

  7. Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link? Human pathology. 2003;34(8):764-9. PubMed PMID: 14506636.

    Article  CAS  Google Scholar 

  8. Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocrine pathology. 2010;21(3):149-53. PubMed PMID: 20506003.

    Article  Google Scholar 

  9. Lucas SD, Karlsson-Parra A, Nilsson B, Grimelius L, Akerstrom G, Rastad J, et al. Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. Human pathology. 1996;27(12):1329-35. PubMed PMID: 8958307.

    Article  CAS  Google Scholar 

  10. Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, et al. Interleukin-1 inhibits human thyroid carcinoma cell growth. The Journal of clinical endocrinology and metabolism. 1992;75(2):596-602. PubMed PMID: 1322431.

    CAS  PubMed  Google Scholar 

  11. Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. The Journal of clinical endocrinology and metabolism. 2013;98(6):2409-14. PubMed PMID: 23609834.

    Article  CAS  Google Scholar 

  12. Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence. Endocrine pathology. 2011;22(3):144-9. PubMed PMID: 21647844.

    Article  Google Scholar 

  13. Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid : official journal of the American Thyroid Association. 1998;8(3):197-202. PubMed PMID: 9545105.

    Article  CAS  Google Scholar 

  14. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid : official journal of the American Thyroid Association. 2009;19(11):1167–214. PubMed PMID: 19860577.

  15. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid : official journal of the American Thyroid Association. 2016;26(1):1-133. PubMed PMID: 26462967. Pubmed Central PMCID: 4739132.

  16. McConahey WM. Hashimoto's thyroiditis. The Medical clinics of North America. 1972;56(4):885-96. PubMed PMID: 5067810.

    Article  CAS  Google Scholar 

  17. Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid : official journal of the American Thyroid Association. 2010;20(12):1341-9. PubMed PMID: 21034228. Pubmed Central PMCID: 4845674.

  18. Lai X, Xia Y, Zhang B, Li J, Jiang Y. A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017;8(37):62414-24. PubMed PMID: 28977955. Pubmed Central PMCID: 5617515.

  19. Azizi G, Keller JM, Lewis M, Piper K, Puett D, Rivenbark KM, et al. Association of Hashimoto's thyroiditis with thyroid cancer. Endocrine-related cancer. 2014;21(6):845-52. PubMed PMID: 25217233. Pubmed Central PMCID: 4187247.

  20. Gul K, Dirikoc A, Kiyak G, Ersoy PE, Ugras NS, Ersoy R, et al. The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid : official journal of the American Thyroid Association. 2010;20(8):873-8. PubMed PMID: 20677997.

    Article  Google Scholar 

  21. Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. Journal of the American College of Surgeons. 2007;204(5):764–73; discussion 73–5. PubMed PMID: 17481480. Pubmed Central PMCID: 2430882.

  22. Matesa-Anic D, Matesa N, Dabelic N, Kusic Z. Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta clinica Croatica. 2009;48(1):9-12. PubMed PMID: 19623865.

    PubMed  Google Scholar 

  23. Anil C, Goksel S, Gursoy A. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid : official journal of the American Thyroid Association. 2010;20(6):601-6. PubMed PMID: 20470208.

    Article  Google Scholar 

  24. Galdiero MR, Varricchi G, Marone G. The immune network in thyroid cancer. Oncoimmunology. 2016;5(6):e1168556. PubMed PMID: 27471646. Pubmed Central PMCID: 4938375.

  25. Bagnasco M, Venuti D, Paolieri F, Torre G, Ferrini S, Canonica GW. Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity. The Journal of clinical endocrinology and metabolism. 1989;69(4):832-6. PubMed PMID: 2789232.

    Article  CAS  Google Scholar 

  26. Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. International journal of surgical pathology. 2002;10(2):141-6. PubMed PMID: 12075407.

    Article  Google Scholar 

  27. Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. The Journal of clinical endocrinology and metabolism. 2012;97(4):1134-45. PubMed PMID: 22278420.

    Article  CAS  Google Scholar 

  28. McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. The Journal of clinical endocrinology and metabolism. 2012;97(8):2682-92. PubMed PMID: 22622023.

    Article  CAS  Google Scholar 

  29. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 1997;275(5302):960-3. PubMed PMID: 9020075.

    Article  CAS  Google Scholar 

  30. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, et al. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. The Journal of clinical endocrinology and metabolism. 2001;86(3):1346-54. PubMed PMID: 11238531.

    CAS  PubMed  Google Scholar 

  31. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. The Journal of clinical endocrinology and metabolism. 1995;80(12):3421-4. PubMed PMID: 8530576.

    CAS  PubMed  Google Scholar 

  32. Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ, Zhu QY. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2016;38(2):763-76. PubMed PMID: 26871894.

    Article  CAS  Google Scholar 

  33. Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI, Tsartsalis AN, Syros PK, Karefilakis CM, et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones. 2010;9(4):312-7. PubMed PMID: 21112862.

  34. Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clinical endocrinology. 2009;71(4):581-6. PubMed PMID: 19222495.

    Article  Google Scholar 

  35. Moon S, Chung HS, Yu JM, Yoo HJ, Park JH, Kim DS, et al. Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies. Endocrinology and metabolism. 2018;33(4):473-84. PubMed PMID: 30513562. Pubmed Central PMCID: 6279904.

  36. Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, et al. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer. Endocrine-related cancer. 2017;24(9):485-93. PubMed PMID: 28696209.

    Article  CAS  Google Scholar 

  37. Carvalho MS, Rosario PW, Mourao GF, Calsolari MR. Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy. Endocrine. 2017;55(3):954-8. PubMed PMID: 27878772.

    Article  CAS  Google Scholar 

  38. Kim YS, Choi HJ, Kim ES. Papillary thyroid carcinoma with thyroiditis: lymph node metastasis, complications. Journal of the Korean Surgical Society. 2013;85(1):20-4. PubMed PMID: 23833756. Pubmed Central PMCID: 3699683.

  39. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism. 1999;84(2):458-63. PubMed PMID: 10022401.

  40. Zhu F, Shen YB, Li FQ, Fang Y, Hu L, Wu YJ. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study. Medicine. 2016;95(6):e2674. PubMed PMID: 26871795. Pubmed Central PMCID: 4753890.

  41. Ieni A, Vita R, Magliolo E, Santarpia M, Di Bari F, Benvenga S, et al. One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007–2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging. Frontiers in endocrinology. 2017;8:337. PubMed PMID: 29250033. Pubmed Central PMCID: 5716977.

  42. Anand A, Singh KR, Kushwaha JK, Hussain N, Sonkar AA. Papillary Thyroid Cancer and Hashimoto's Thyroiditis: An Association Less Understood. Indian journal of surgical oncology. 2014;5(3):199-204. PubMed PMID: 25419066. Pubmed Central PMCID: 4235865.

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey

    Berna İmge Aydoğan, Adile Begüm Bahçecioğlu Mutlu, Sevim Güllü, Rıfat Emral, Özgür Demir, Mustafa Şahin, Vedia Tonyukuk Gedik, Demet Çorapçıoğlu & Murat Faik Erdoğan

  2. Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey

    Seher Yüksel & Serpil Dizbay Sak

Authors
  1. Berna İmge Aydoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adile Begüm Bahçecioğlu Mutlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seher Yüksel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sevim Güllü
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rıfat Emral
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Özgür Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mustafa Şahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vedia Tonyukuk Gedik
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Demet Çorapçıoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Serpil Dizbay Sak
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Murat Faik Erdoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Berna İmge Aydoğan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aydoğan, B.İ., Mutlu, A.B.B., Yüksel, S. et al. The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer. Endocr Pathol 32, 280–287 (2021). https://doi.org/10.1007/s12022-020-09653-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-020-09653-y

Keywords

Search

Navigation